Format

Send to

Choose Destination
Pharmacol Ther. 1993 Jan;57(1):79-128.

Tumor necrosis factor activities and cancer therapy--a perspective.

Author information

1
Cytoclonal Pharmaceutics Inc., Dallas, TX 75235.

Abstract

Tumor necrosis factor (TNF) is a multifunctional cytokine which has excited and fascinated numerous investigators and commercial entities due to its promise as a therapeutic agent against cancer and as a target for drugs treating septic shock. TNF is a protein having cytotoxic, cytostatic, immunomodulatory as well as several other activities and is also involved in septic shock. This review covers the structure of TNF and its receptors, various in vitro activities and in vivo activities based on studies in animal model systems. The role of TNF as an anticancer therapeutic agent, based on various phase I and phase II clinical studies, has also been considered. The review concludes with several considerations for increasing the therapeutic utility of TNF in terms of targeting, toxicity and half-life.

PMID:
8390056
DOI:
10.1016/0163-7258(93)90037-e
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center